Regulation of capsule in Neisseria meningitidis

References

• Agarwal S, Vasudhev S, DeOliveira RB, Ram S. (2014). Inhibition of the classical pathway of complement by meningococcal capsular polysaccharides. J Immunol 193:1855–63
   PubMed Web of Science ®Google Scholar
• Alcala B, Arreaza L, Salcedo C, et al. (2002). Capsule switching among C:2b:P1.2,5 meningococcal epidemic strains after mass immunization campaign, Spain. Emerg Infect Dis 8:1512–14
   PubMed Web of Science ®Google Scholar
• Artenstein MS, Gold R, Zimmerly JG, et al. (1970). Prevention of meningococcal disease by group C polysaccharide vaccine. N Engl J Med 282:417–20
   PubMed Web of Science ®Google Scholar
• Bartley SN, Tzeng YL, Heel K, et al. (2013). Attachment and invasion of Neisseria meningitidis to host cells is related to surface hydrophobicity, bacterial cell size and capsule. PLoS One 8:e55798
   PubMedGoogle Scholar
• Beddek AJ, Li MS, Kroll JS, et al. (2009). Evidence for capsule switching between carried and disease-causing Neisseria meningitidis strains. Infect Immun 77:2989–94
   PubMed Web of Science ®Google Scholar
• Bennett DE, Cafferkey MT. (2006). Consecutive use of two multiplex PCR-based assays for simultaneous identification and determination of capsular status of nine common Neisseria meningitidis serogroups associated with invasive disease. J Clin Microbiol 44:1127–31
   PubMed Web of Science ®Google Scholar
• Bergfeld AK, Claus H, Lorenzen NK, et al. (2009). The polysialic acid-specific O-acetyltransferase OatC from Neisseria meningitidis serogroup C evolved apart from other bacterial sialate O-acetyltransferases. J Biol Chem 284:6–16
   PubMed Web of Science ®Google Scholar
• Berry DS, Lynn F, Lee CH, et al. (2002). Effect of O acetylation of Neisseria meningitidis serogroup A capsular polysaccharide on development of functional immune responses. Infect Immun 70:3707–13
   PubMed Web of Science ®Google Scholar
• Bilukha OO, Rosenstein N. (2005). Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 54:1–21
   PubMedGoogle Scholar
• Carter NJ. (2013). Multicomponent meningococcal serogroup B vaccine (4CMenB; Bexsero): a review of its use in primary and booster vaccination. BioDrugs 27:263–74
   PubMed Web of Science ®Google Scholar
• Claus H, Borrow R, Achtman M, et al. (2004). Genetics of capsule O-acetylation in serogroup C, W-135 and Y meningococci. Mol Microbiol 51:227–39
   PubMed Web of Science ®Google Scholar
• Claus H, Friedrich A, Frosch M, Vogel U. (2000). Differential distribution of novel restriction-modification systems in clonal lineages of Neisseria meningitidis. J Bacteriol 182:1296–303
   PubMed Web of Science ®Google Scholar
• Claus H, Maiden MC, Maag R, et al. (2002). Many carried meningococci lack the genes required for capsule synthesis and transport. Microbiology 148:1813–19
   PubMed Web of Science ®Google Scholar
• Claus H, Stummeyer K, Batzilla J, et al. (2009). Amino acid 310 determines the donor substrate specificity of serogroup W-135 and Y capsule polymerases of Neisseria meningitidis. Mol Microbiol 71:960–71
   PubMed Web of Science ®Google Scholar
• Collard JM, Issaka B, Zaneidou M, et al. (2013). Epidemiological changes in meningococcal meningitis in Niger from 2008 to 2011 and the impact of vaccination. BMC Infect Dis 13:576
   PubMed Web of Science ®Google Scholar
• Deghmane AE, Giorgini D, Larribe M, et al. (2002). Down-regulation of pili and capsule of Neisseria meningitidis upon contact with epithelial cells is mediated by CrgA regulatory protein. Mol Microbiol 43:1555–64
   PubMed Web of Science ®Google Scholar
• Deretic V, Konyecsni WM. (1989). Control of mucoidy in Pseudomonas aeruginosa: transcriptional regulation of algR and identification of the second regulatory gene, algQ. J Bacteriol 171:3680–8
   PubMed Web of Science ®Google Scholar
• Dietrich G, Kurz S, Hubner C, et al. (2003). Transcriptome analysis of Neisseria meningitidis during infection. J Bacteriol 185:155–64
   PubMed Web of Science ®Google Scholar
• Dolan-Livengood JM, Miller YK, Martin LE, et al. (2003). Genetic basis for nongroupable Neisseria meningitidis. J Infect Dis 187:1616–28
   PubMed Web of Science ®Google Scholar
• Echenique-Rivera H, Muzzi A, Del Tordello E, et al. (2011). Transcriptome analysis of Neisseria meningitidis in human whole blood and mutagenesis studies identify virulence factors involved in blood survival. PLoS Pathog 7:e1002027
   PubMed Web of Science ®Google Scholar
• Edwards U, Muller A, Hammerschmidt S, et al. (1994). Molecular analysis of the biosynthesis pathway of the alpha-2–>8 polysialic acid capsule by Neisseria meningitidis serogroup B. Mol Microbiol 14:141–9
   PubMed Web of Science ®Google Scholar
• Ellison RTd, Kohler PF, Curd JG, et al. (1983). Prevalence of congenital or acquired complement deficiency in patients with sporadic meningocococcal disease. N Engl J Med 308:913–16
   PubMed Web of Science ®Google Scholar
• Fiebig T, Berti F, Freiberger F, et al. (2014a). Functional expression of the capsule polymerase of Neisseria meningitidis serogroup X: a new perspective for vaccine development. Glycobiology 24:150–8
   PubMed Web of Science ®Google Scholar
• Fiebig T, Freiberger F, Pinto V, et al. (2014b). Molecular cloning and functional characterization of components of the capsule biosynthesis complex of Neisseria meningitidis serogroup A: toward in vitro vaccine production. J Biol Chem 289:19395–407
   PubMed Web of Science ®Google Scholar
• Figueroa J, Andreoni J, Densen P. (1993). Complement deficiency states and meningococcal disease. Immunol Res 12:295–311
   PubMed Web of Science ®Google Scholar
• Finne J, Leinonen M, Makela PH. (1983). Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet 2:355–7
   PubMed Web of Science ®Google Scholar
• Frasch CE, Preziosi MP, LaForce FM. (2012). Development of a group A meningococcal conjugate vaccine, MenAfriVac(TM). Hum Vaccin Immunother 8:715–24
   PubMed Web of Science ®Google Scholar
• Freiberger F, Claus H, Gunzel A, et al. (2007). Biochemical characterization of a Neisseria meningitidis polysialyltransferase reveals novel functional motifs in bacterial sialyltransferases. Mol Microbiol 65:1258–75
   PubMed Web of Science ®Google Scholar
• Frosch M, Meyer TF. (1992). Transformation-mediated exchange of virulence determinants by co-cultivation of pathogenic Neisseriae. FEMS Microbiol Lett 79:345–9
   Google Scholar
• Fusco PC, Farley EK, Huang CH, et al. (2007). Protective meningococcal capsular polysaccharide epitopes and the role of O acetylation. Clin Vaccine Immunol 14:577–84
   PubMed Web of Science ®Google Scholar
• Gilbert M, Watson DC, Cunningham AM, et al. (1996). Cloning of the lipooligosaccharide alpha-2,3-sialyltransferase from the bacterial pathogens Neisseria meningitidis and Neisseria gonorrhoeae. J Biol Chem 271:28271–6
   PubMed Web of Science ®Google Scholar
• Granoff DM. (2013). Commentary: European Medicines Agency recommends approval of a broadly protective vaccine against serogroup B meningococcal disease. Pediatr Infect Dis J 32:372–3
   PubMed Web of Science ®Google Scholar
• Granoff DM, Gupta RK, Belshe RB, Anderson EL. (1998). Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination. J Infect Dis 178:870–4
   PubMed Web of Science ®Google Scholar
• Gudlavalleti SK, Datta AK, Tzeng YL, et al. (2004). The Neisseria meningitidis serogroup A capsular polysaccharide O-3 and O-4 acetyltransferase. J Biol Chem 279:42765–73
   PubMed Web of Science ®Google Scholar
• Hammerschmidt S, Hilse R, van Putten JP, et al. (1996a). Modulation of cell surface sialic acid expression in Neisseria meningitidis via a transposable genetic element. EMBO J 15:192–8
   PubMed Web of Science ®Google Scholar
• Hammerschmidt S, Muller A, Sillmann H, et al. (1996b). Capsule phase variation in Neisseria meningitidis serogroup B by slipped-strand mispairing in the polysialyltransferase gene (siaD): correlation with bacterial invasion and the outbreak of meningococcal disease. Mol Microbiol 20:1211–20
   PubMed Web of Science ®Google Scholar
• Harrison LH, Shutt KA, Schmink SE, et al. (2010). Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era–United States, 2000-2005. J Infect Dis 201:1208–24
   PubMed Web of Science ®Google Scholar
• Harrison OB, Claus H, Jiang Y, et al. (2013). Description and nomenclature of Neisseria meningitidis capsule locus. Emerg Infect Dis 19:566–73
   PubMed Web of Science ®Google Scholar
• Heath A, DiRita VJ, Barg NL, Engleberg NC. (1999). A two-component regulatory system, CsrR-CsrS, represses expression of three Streptococcus pyogenes virulence factors, hyaluronic acid capsule, streptolysin S, and pyrogenic exotoxin B. Infect Immun 67:5298–305
   PubMed Web of Science ®Google Scholar
• Hobb RI, Tzeng YL, Choudhury BP, et al. (2010). Requirement of NMB0065 for connecting assembly and export of sialic acid capsular polysaccharides in Neisseria meningitidis. Microbes Infect 12:476–87
   PubMed Web of Science ®Google Scholar
• Ieva R, Alaimo C, Delany I, et al. (2005). CrgA is an inducible LysR-type regulator of Neisseria meningitidis, acting both as a repressor and as an activator of gene transcription. J Bacteriol 187:3421–30
   PubMed Web of Science ®Google Scholar
• Johansson J, Mandin P, Renzoni A, et al. (2002). An RNA thermosensor controls expression of virulence genes in Listeria monocytogenes. Cell 110:551–61
   PubMed Web of Science ®Google Scholar
• Jones A, Georg M, Maudsdotter L, Jonsson AB. (2009). Endotoxin, capsule, and bacterial attachment contribute to Neisseria meningitidis resistance to the human antimicrobial peptide LL-37. J Bacteriol 191:3861–8
   PubMed Web of Science ®Google Scholar
• Kertesz DA, Coulthart MB, Ryan JA, et al. (1998). Serogroup B, electrophoretic type 15 Neisseria meningitidis in Canada. J Infect Dis 177:1754–7
   PubMed Web of Science ®Google Scholar
• Kocabas C, Katsenelson N, Kanswal S, et al. (2007). Neisseria meningitidis type C capsular polysaccharide inhibits lipooligosaccharide-induced cell activation by binding to CD14. Cell Microbiol 9:1297–310
   PubMed Web of Science ®Google Scholar
• Kristiansen PA, Diomande F, Ba AK, et al. (2013). Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity. Clin Infect Dis 56:354–63
   PubMed Web of Science ®Google Scholar
• Kriz P, Giorgini D, Musilek M, et al. (1999). Microevolution through DNA exchange among strains of Neisseria meningitidis isolated during an outbreak in the Czech Republic. Res Microbiol 150:273–80
   PubMed Web of Science ®Google Scholar
• Kugelberg E, Gollan B, Farrance C, et al. (2010). The influence of IS1301 in the capsule biosynthesis locus on meningococcal carriage and disease. PLoS One 5:e9413
   PubMedGoogle Scholar
• Kurz S, Hubner C, Aepinus C, et al. (2003). Transcriptome-based antigen identification for Neisseria meningitidis. Vaccine 21:768–75
   PubMed Web of Science ®Google Scholar
• Larue K, Ford RC, Willis LM, Whitfield C. (2011). Functional and structural characterization of polysaccharide co-polymerase proteins required for polymer export in ATP-binding cassette transporter-dependent capsule biosynthesis pathways. J Biol Chem 286:16658–68
   PubMed Web of Science ®Google Scholar
• Lavitola A, Bucci C, Salvatore P, et al. (1999). Intracistronic transcription termination in polysialyltransferase gene (siaD) affects phase variation in Neisseria meningitidis. Mol Microbiol 33:119–27
   PubMed Web of Science ®Google Scholar
• Lee HJ, Rakic B, Gilbert M, et al. (2009). Structural and kinetic characterizations of the polysialic acid O-acetyltransferase OatWY from Neisseria meningitidis. J Biol Chem 284:24501–11
   PubMed Web of Science ®Google Scholar
• Lepow ML, Beeler J, Randolph M, et al. (1986). Reactogenicity and immunogenicity of a quadrivalent combined meningococcal polysaccharide vaccine in children. J Infect Dis 154:1033–6
   PubMed Web of Science ®Google Scholar
• Lewis LA, Ram S. (2014). Meningococcal disease and the complement system. Virulence 5:98–126
   PubMed Web of Science ®Google Scholar
• Li S, Rouphael N, Duraisingham S, et al. (2014). Molecular signatures of antibody responses derived from a systems biology study of five human vaccines. Nat Immunol 15:195–204
   PubMed Web of Science ®Google Scholar
• Loh E, Kugelberg E, Tracy A, et al. (2013). Temperature triggers immune evasion by Neisseria meningitidis. Nature 502:237–40
   PubMed Web of Science ®Google Scholar
• Longworth E, Fernsten P, Mininni TL, et al. (2002). O-Acetylation status of the capsular polysaccharides of serogroup Y and W135 meningococci isolated in the UK. FEMS Immunol Med Microbiol 32:119–23
   PubMedGoogle Scholar
• Mackinnon FG, Borrow R, Gorringe AR, et al. (1993). Demonstration of lipooligosaccharide immunotype and capsule as virulence factors for Neisseria meningitidis using an infant mouse intranasal infection model. Microb Pathog 15:359–66
   PubMed Web of Science ®Google Scholar
• MacLennan J, Obaro S, Deeks J, et al. (2001). Immunologic memory 5 years after meningococcal A/C conjugate vaccination in infancy. J Infect Dis 183:97–104
   PubMed Web of Science ®Google Scholar
• Martin P, Sun L, Hood DW, Moxon ER. (2004). Involvement of genes of genome maintenance in the regulation of phase variation frequencies in Neisseria meningitidis. Microbiology 150:3001–12
   PubMed Web of Science ®Google Scholar
• Masson L, Holbein BE. (1985). Role of lipid intermediate(s) in the synthesis of serogroup B Neisseria meningitidis capsular polysaccharide. J Bacteriol 161:861–7
   PubMed Web of Science ®Google Scholar
• McIntyre PB, O'Brien KL, Greenwood B, van de Beek D. (2012). Effect of vaccines on bacterial meningitis worldwide. Lancet 380:1703–11
   PubMed Web of Science ®Google Scholar
• McNeil LK, Zagursky RJ, Lin SL, et al. (2013). Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal disease. Microbiol Mol Biol Rev 77:234–52
   PubMed Web of Science ®Google Scholar
• Michon F, Huang CH, Farley EK, et al. (2000). Structure activity studies on group C meningococcal polysaccharide-protein conjugate vaccines: effect of O-acetylation on the nature of the protective epitope. Dev Biol (Basel) 103:151–60
   PubMedGoogle Scholar
• Morelle S, Carbonnelle E, Nassif X. (2003). The REP2 repeats of the genome of Neisseria meningitidis are associated with genes coordinately regulated during bacterial cell interaction. J Bacteriol 185:2618–27
   PubMed Web of Science ®Google Scholar
• Muindi KM, McCarthy PC, Wang T, et al. (2014). Characterization of the meningococcal serogroup X capsule N-acetylglucosamine-1-phosphotransferase. Glycobiology 24:139–49
   PubMed Web of Science ®Google Scholar
• Peterson DC, Arakere G, Vionnet J, et al. (2011). Characterization and acceptor preference of a soluble meningococcal group C polysialyltransferase. J Bacteriol 193:1576–82
   PubMed Web of Science ®Google Scholar
• Ram S, Lewis LA, Agarwal S. (2011). Meningococcal group W-135 and Y capsular polysaccharides paradoxically enhance activation of the alternative pathway of complement. J Biol Chem 286:8297–307
   PubMed Web of Science ®Google Scholar
• Ram S, Mackinnon FG, Gulati S, et al. (1999). The contrasting mechanisms of serum resistance of Neisseria gonorrhoeae and group B Neisseria meningitidis. Mol Immunol 36:915–28
   PubMed Web of Science ®Google Scholar
• Ramsay ME, Andrews NJ, Trotter CL, et al. (2003). Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis. BMJ 326:365–6
   PubMed Web of Science ®Google Scholar
• Richmond P, Borrow R, Findlow J, et al. (2001). Evaluation of De-O-acetylated meningococcal C polysaccharide-tetanus toxoid conjugate vaccine in infancy: reactogenicity, immunogenicity, immunologic priming, and bactericidal activity against O-acetylated and De-O-acetylated serogroup C strains. Infect Immun 69:2378–82
   PubMed Web of Science ®Google Scholar
• Romanow A, Haselhorst T, Stummeyer K, et al. (2013). Biochemical and biophysical characterization of the sialyl-/hexosyltransferase synthesizing the meningococcal serogroup W135 heteropolysaccharide capsule. J Biol Chem 288:11718–30
   PubMed Web of Science ®Google Scholar
• Romanow A, Keys TG, Stummeyer K, et al. (2014). Dissection of hexosyl- and sialyltransferase domains in the bifunctional capsule polymerases from Neisseria meningitidis W and Y defines a new sialyltransferase family. J Biol Chem 289:33945–57
   PubMed Web of Science ®Google Scholar
• Rosenstein NE, Fischer M, Tappero JW. (2001a). Meningococcal vaccines. Infect Dis Clin North Am 15:155–69
   PubMed Web of Science ®Google Scholar
• Rosenstein NE, Perkins BA, Stephens DS, et al. (1999). The changing epidemiology of meningococcal disease in the United States, 1992–1996. J Infect Dis 180:1894–901
   PubMed Web of Science ®Google Scholar
• Rosenstein NE, Perkins BA, Stephens DS, et al. (2001b). Meningococcal disease. N Engl J Med 344:1378–88
   PubMed Web of Science ®Google Scholar
• Sadarangani M, Pollard AJ. (2010). Serogroup B meningococcal vaccines – an unfinished story. Lancet Infect Dis 10:112–24
   PubMed Web of Science ®Google Scholar
• Schoen C, Blom J, Claus H, et al. (2008). Whole-genome comparison of disease and carriage strains provides insights into virulence evolution in Neisseria meningitidis. Proc Natl Acad Sci USA 105:3473–8
   PubMed Web of Science ®Google Scholar
• Simoes MJ, Cunha M, Almeida F, et al. (2009). Molecular surveillance of Neisseria meningitidis capsular switching in Portugal, 2002-2006. Epidemiol Infect 137:161–5
   PubMed Web of Science ®Google Scholar
• Snyder LA, Butcher SA, Saunders NJ. (2001). Comparative whole-genome analyses reveal over 100 putative phase-variable genes in the pathogenic Neisseria spp. Microbiology 147:2321–32
   PubMed Web of Science ®Google Scholar
• Spinosa MR, Progida C, Tala A, et al. (2007). The Neisseria meningitidis capsule is important for intracellular survival in human cells. Infect Immun 75:3594–603
   PubMed Web of Science ®Google Scholar
• Stefanelli P, Fazio C, Neri A, et al. (2003). First report of capsule replacement among electrophoretic type 37 Neisseria meningitidis strains in Italy. J Clin Microbiol 41:5783–6
   PubMed Web of Science ®Google Scholar
• Stephens DS, Spellman PA, Swartley JS. (1993). Effect of the (a 2–>8)-linked polysialic acid capsule on adherence of Neisseria meningitidis to human mucosal cells. J Infect Dis 167:475–9
   PubMed Web of Science ®Google Scholar
• Stout V, Gottesman S. (1990). RcsB and RcsC: a two-component regulator of capsule synthesis in Escherichia coli. J Bacteriol 172:659–69
   PubMed Web of Science ®Google Scholar
• Swartley JS, Liu LJ, Miller YK, et al. (1998). Characterization of the gene cassette required for biosynthesis of the (a1 → 6)-linked N-acetyl-D-mannosamine-1-phosphate capsule of serogroup A Neisseria meningitidis. J Bacteriol 180:1533–9
   PubMed Web of Science ®Google Scholar
• Swartley JS, Marfin AA, Edupuganti S, et al. (1997). Capsule switching of Neisseria meningitidis. Proc Natl Acad Sci USA 94:271–6
   PubMed Web of Science ®Google Scholar
• Taha MK, Achtman M, Alonso JM, et al. (2000). Serogroup W135 meningococcal disease in Hajj pilgrims. Lancet 356:2159
   PubMed Web of Science ®Google Scholar
• Tala A, Cogli L, De Stefano M, et al. (2014). Serogroup-specific interaction of Neisseria meningitidis capsular polysaccharide with host cell microtubules and effects on tubulin polymerization. Infect Immun 82:265–74
   PubMed Web of Science ®Google Scholar
• Tala A, Progida C, De Stefano M, et al. (2008). The HrpB-HrpA two-partner secretion system is essential for intracellular survival of Neisseria meningitidis. Cell Microbiol 10:2461–82
   PubMed Web of Science ®Google Scholar
• Tettelin H, Saunders NJ, Heidelberg J, et al. (2000). Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science 287:1809–15
   PubMed Web of Science ®Google Scholar
• Trotter CL, Andrews NJ, Kaczmarski EB, et al. (2004). Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet 364:365–7
   PubMed Web of Science ®Google Scholar
• Troy FA, Vijay IK, Tesche N. (1975). Role of undecaprenyl phosphate in synthesis of polymers containing sialic acid in Escherichia coli. J Biol Chem 250:156–63
   PubMed Web of Science ®Google Scholar
• Tsang RS, Law DK, Tyler SD, et al. (2005). Potential capsule switching from serogroup Y to B: the characterization of three such Neisseria meningitidis isolates causing invasive meningococcal disease in Canada. Can J Infect Dis Med Microbiol 16:171–4
   PubMedGoogle Scholar
• Tzeng YL, Datta A, Strole C, et al. (2002). KpsF is the arabinose-5-phosphate isomerase required for 3-deoxy-D-manno-octulosonic acid biosynthesis and for both lipooligosaccharide assembly and capsular polysaccharide expression in Neisseria meningitidis. J Biol Chem 277:24103–13
   PubMed Web of Science ®Google Scholar
• Tzeng YL, Datta AK, Strole CA, et al. (2005). Translocation and surface expression of lipidated serogroup B capsular polysaccharide in Neisseria meningitidis. Infect Immun 73:1491–505
   PubMed Web of Science ®Google Scholar
• Tzeng YL, Kahler CM, Zhang X, Stephens DS. (2008). MisR/MisS two-component regulon in Neisseria meningitidis. Infect Immun 76:704–16
   PubMed Web of Science ®Google Scholar
• Tzeng YL, Martin LE, Stephens DS. (2013). Environmental survival of Neisseria meningitidis. Epidemiol Infect 142:187–90
   PubMed Web of Science ®Google Scholar
• Tzeng YL, Noble C, Stephens DS. (2003). Genetic basis for biosynthesis of the (alpha 1–>4)-linked N-acetyl-D-glucosamine 1-phosphate capsule of Neisseria meningitidis serogroup X. Infect Immun 71:6712–20
   PubMed Web of Science ®Google Scholar
• Tzeng YL, Swartley JS, Miller YK, et al. (2001). Transcriptional regulation of divergent capsule biosynthesis and transport operon promoters in serogroup B Neisseria meningitidis. Infect Immun 69:2502–11
   PubMed Web of Science ®Google Scholar
• Uria MJ, Zhang Q, Li Y, et al. (2008). A generic mechanism in Neisseria meningitidis for enhanced resistance against bactericidal antibodies. J Exp Med 205:1423–34
   PubMed Web of Science ®Google Scholar
• Vipond C, Care R, Feavers IM. (2012). History of meningococcal vaccines and their serological correlates of protection. Vaccine 30:B10–17
   PubMed Web of Science ®Google Scholar
• Virji M, Makepeace K, Ferguson DJ, et al. (1993). Meningococcal Opa and Opc proteins: their role in colonization and invasion of human epithelial and endothelial cells. Mol Microbiol 10:499–510
   PubMed Web of Science ®Google Scholar
• Vogel U, Claus H, Frosch M. (2000). Rapid serogroup switching in Neisseria meningitidis. N Engl J Med 342:219–20
   PubMed Web of Science ®Google Scholar
• Von Loewenich FD, Wintermeyer E, Dumig M, Frosch M. (2001). Analysis of transcriptional control mechanisms of capsule expression in Neisseria meningitidis. Int J Med Microbiol 291:361–9
   PubMed Web of Science ®Google Scholar
• Wang Q, Shao Z, Wang X, et al. (2010). Genetic study of capsular switching between Neisseria meningitidis sequence type 7 serogroup A and C strains. Infect Immun 78:3883–8
   PubMed Web of Science ®Google Scholar
• Willis LM, Stupak J, Richards MR, et al. (2013). Conserved glycolipid termini in capsular polysaccharides synthesized by ATP-binding cassette transporter-dependent pathways in Gram-negative pathogens. Proc Natl Acad Sci USA 110:7868–73
   PubMed Web of Science ®Google Scholar
• Willis LM, Whitfield C. (2013a). KpsC and KpsS are retaining 3-deoxy-D-manno-oct-2-ulosonic acid (Kdo) transferases involved in synthesis of bacterial capsules. Proc Natl Acad Sci USA 110:20753–8
   PubMed Web of Science ®Google Scholar
• Willis LM, Whitfield C. (2013b). Structure, biosynthesis, and function of bacterial capsular polysaccharides synthesized by ABC transporter-dependent pathways. Carbohydr Res 378:35–44
   PubMed Web of Science ®Google Scholar
• Yi K, Stephens DS, Stojiljkovic I. (2003). Development and evaluation of an improved mouse model of meningococcal colonization. Infect Immun 71:1849–55
   PubMed Web of Science ®Google Scholar
• Zhu H, Wang Q, Wen L, et al. (2012). Development of a multiplex PCR assay for detection and genogrouping of Neisseria meningitidis. J Clin Microbiol 50:46–51
   PubMed Web of Science ®Google Scholar
• Zimmer SM, Stephens DS. (2006). Serogroup B meningococcal vaccines. Curr Opin Investig Drugs 7:733–9
   PubMed Web of Science ®Google Scholar